Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038558
Status:
COMPLETED
Last Update Posted:
2018-10-31
First Post:
2002-05-31
Brief Title:
Prophylactic Use of Filgrastim SD01 in Patients With Hodgkins Disease Receiving ABVD Chemotherapy
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hodgkin Disease |
Keywords:
| Name | View |
|---|---|
| granulocyte colony-stimulating factor | View |
| Hodgkins lymphoma | View |
| Dacarbazine | View |
| DTIC | View |
| DTIC-Dome | View |
| Vinblastine | View |
| Velban | View |
| Bleomycin sulfate | View |
| Blenoxane | View |
| BLM | View |
| Doxorubicin Hydrochloride | View |
| Adriamycin | View |
| Filgrastim | View |
| G-CSF | View |
| Neupogen | View |
| Pegfilgrastim | View |